Luigi Cerbone

713 total citations
40 papers, 308 citations indexed

About

Luigi Cerbone is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Luigi Cerbone has authored 40 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Luigi Cerbone's work include Renal cell carcinoma treatment (11 papers), Cancer Genomics and Diagnostics (7 papers) and Renal and related cancers (6 papers). Luigi Cerbone is often cited by papers focused on Renal cell carcinoma treatment (11 papers), Cancer Genomics and Diagnostics (7 papers) and Renal and related cancers (6 papers). Luigi Cerbone collaborates with scholars based in Italy, France and Switzerland. Luigi Cerbone's co-authors include Carlo Cattrini, Elisa Zanardi, Francesco Boccardo, Carlo Messina, Giulia Buzzatti, A. Rubagotti, Marco Messina, Maria Maddalena Latocca, Bernard Escudier and Laurence Albigès and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Luigi Cerbone

38 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luigi Cerbone Italy 10 222 125 109 93 30 40 308
Susan E. Jorge Brazil 7 200 0.9× 137 1.1× 112 1.0× 51 0.5× 41 1.4× 22 303
Umair Majeed United States 5 159 0.7× 149 1.2× 95 0.9× 81 0.9× 14 0.5× 27 295
Guilherme Harada Brazil 11 161 0.7× 155 1.2× 90 0.8× 66 0.7× 14 0.5× 40 317
Daniela Bärtschi Switzerland 5 141 0.6× 132 1.1× 156 1.4× 81 0.9× 10 0.3× 6 292
Annalisa Guida Italy 11 246 1.1× 165 1.3× 108 1.0× 72 0.8× 13 0.4× 39 323
Letizia Laera Italy 12 179 0.8× 119 1.0× 101 0.9× 72 0.8× 21 0.7× 32 329
Tristan Maurina France 10 154 0.7× 108 0.9× 118 1.1× 73 0.8× 18 0.6× 30 293
Paule Augereau France 11 133 0.6× 224 1.8× 102 0.9× 80 0.9× 46 1.5× 45 402
Kaoru Irisa Japan 9 236 1.1× 214 1.7× 76 0.7× 48 0.5× 17 0.6× 16 333
Diana Gernhardt United States 7 200 0.9× 248 2.0× 135 1.2× 56 0.6× 14 0.5× 8 338

Countries citing papers authored by Luigi Cerbone

Since Specialization
Citations

This map shows the geographic impact of Luigi Cerbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Cerbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Cerbone more than expected).

Fields of papers citing papers by Luigi Cerbone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Cerbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Cerbone. The network helps show where Luigi Cerbone may publish in the future.

Co-authorship network of co-authors of Luigi Cerbone

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Cerbone. A scholar is included among the top collaborators of Luigi Cerbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Cerbone. Luigi Cerbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faccioli, Eleonora, Federica Grosso, Andrea Dell’Amore, et al.. (2024). Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report. Frontiers in Oncology. 14. 1378530–1378530. 1 indexed citations
2.
Calabrò, Luana, Giuseppe Bronte, Federica Grosso, et al.. (2024). Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream. Frontiers in Immunology. 14. 1333661–1333661. 3 indexed citations
3.
Grosso, Federica, Luigi Cerbone, & Alessandra Curioni‐Fontecedro. (2024). MARS 2 trial: the future of pleurectomy decortication in pleural mesothelioma. The Lancet Respiratory Medicine. 12(6). 423–424. 1 indexed citations
4.
Cerbone, Luigi, Sara Delfanti, Marinella Bertolotti, et al.. (2023). Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens. Thoracic Cancer. 14(5). 524–527. 4 indexed citations
5.
Cerbone, Luigi, et al.. (2023). Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. Cancers. 15(24). 5716–5716. 1 indexed citations
6.
Cerbone, Luigi, Pasquale Rescigno, Fabio Catalano, et al.. (2022). Combined Response of Advanced Cutaneous Squamous Cell Carcinoma and Renal Cell Carcinoma to Immunotherapy: A Case Report. Immunotherapy. 14(18). 1419–1427.
7.
Rebuzzi, Sara Elena, Giuseppe Luigi Banna, Luigi Cerbone, et al.. (2021). Durable Response after Immunotherapy Discontinuation for Delayed and Severe Immune-related Adverse Event: A Case Report. Immunotherapy. 13(17). 1379–1386. 2 indexed citations
8.
Carril-Ajuria, Lucía, Émeline Colomba, Luigi Cerbone, et al.. (2021). Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma. European Journal of Cancer. 151. 106–114. 24 indexed citations
9.
Aldea, Mihaela, Claudia Parisi, Luigi Cerbone, et al.. (2021). 1344P Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC). Annals of Oncology. 32. S1024–S1025. 3 indexed citations
10.
Cerbone, Luigi, Vincenzo Di Nunno, Carolina Alves Costa Silva, et al.. (2021). Activity of Systemic Treatments After Cabozantinib Failure in Advanced Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer. 20(1). 80–87. 6 indexed citations
11.
Cerbone, Luigi, Arthur Géraud, Édouard Auclin, et al.. (2021). Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study. ESMO Open. 6(6). 100312–100312. 25 indexed citations
12.
Rossi, Giovanni, Lodovica Zullo, Luigi Cerbone, et al.. (2020). ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium. Expert Opinion on Pharmacotherapy. 21(6). 679–686. 2 indexed citations
13.
Genova, Carlo, Giovanni Rossi, Marco Tagliamento, et al.. (2020). Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives. Expert Review of Respiratory Medicine. 14(4). 367–383. 21 indexed citations
14.
Cerbone, Luigi, et al.. (2020). Combination therapy in metastatic renal cell carcinoma: Back to the future?. Seminars in Oncology. 47(6). 361–366. 12 indexed citations
15.
Cerbone, Luigi, et al.. (2020). Abscopal Effect After Hypofractionated Radiotherapy in Metastatic Renal Cell Carcinoma Pretreated with Pazopanib. Immunotherapy. 12(12). 869–878. 5 indexed citations
16.
Aldea, Mihaela, Luigi Cerbone, Pernelle Lavaud, et al.. (2020). 638P Meningeal metastases (MM) in patients with metastatic castration resistant prostate cancer (mCRPC). Annals of Oncology. 31. S525–S525. 3 indexed citations
17.
Cerbone, Luigi, Vincenzo Di Nunno, Ronan Flippot, et al.. (2020). 743P Activity of systemic therapies after cabozantinib (CABO) in patients (pts) with metastatic renal cell carcinoma (mRCC). Annals of Oncology. 31. S577–S577. 1 indexed citations
18.
Genova, Carlo, Gemma Rossi, Aldo Pezzuto, et al.. (2019). P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial). Journal of Thoracic Oncology. 14(10). S829–S830. 2 indexed citations
19.
Cattrini, Carlo, A. Rubagotti, Pier Vitale Nuzzo, et al.. (2018). Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome. Clinical Genitourinary Cancer. 16(6). e1257–e1265. 11 indexed citations
20.
Messina, Carlo, Carlo Cattrini, Giulia Buzzatti, et al.. (2018). CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials. Breast Cancer Research and Treatment. 172(1). 9–21. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan E. Jorge Breakdown of academic impact, for papers by Umair Majeed Breakdown of academic impact, for papers by Guilherme Harada Breakdown of academic impact, for papers by Daniela Bärtschi Breakdown of academic impact, for papers by Annalisa Guida Breakdown of academic impact, for papers by Letizia Laera Breakdown of academic impact, for papers by Tristan Maurina Breakdown of academic impact, for papers by Paule Augereau Breakdown of academic impact, for papers by Kaoru Irisa Breakdown of academic impact, for papers by Diana Gernhardt
Rankless by CCL
2026